J&J | Les Intérêts Débiteurs Sur La Dette



Interest Expense On Debt Changement Date
AbbVie USD 610M 19M 2024-12
Abbott USD 49M 4M 2025-03
Amgen USD 747M 29M 2024-12
AstraZeneca 429M 28M 2024-12
Baxter International USD 100M 1000K 2024-12
Bayer 703M 61M 2024-12
Becton, Dickinson and Co. USD 155M 0 2024-12
Biogen USD 60M 200K 2024-12
Boston Scientific USD 82M 2M 2025-03
Bristol-Myers Squibb USD 494M 2M 2025-03
CONMED USD 8.86M 395K 2024-12
Cooper Companies USD 26M 1000K 2025-01
Dexcom USD 4.9M 200K 2024-12
Edwards Lifesciences 15.5M 1000K 2024-06
Eli Lilly USD 224.7M 78.4M 2024-12
Gilead Sciences USD 260M 12M 2025-03
GlaxoSmithKline 162M 11M 2025-03
Globus Medical -815000 1.59M 2024-12
Hologic USD 30.5M 1.5M 2024-12
Indivior 9M 1000K 2024-09
Insulet USD -1600000 6.8M 2024-12
Integra LifeSciences USD 18.98M 389K 2024-12
Intuitive Surgical 74.9M 18.8M 2024-12
J&J USD 128M 9M 2025-03
Medtronic USD 179M 30M 2025-01
Merck USD 328M 2M 2024-12
Merit Medical Systems USD 6.57M 1.42M 2025-03
Novartis USD 275M 11M 2024-12
Pfizer USD 654M 85M 2025-03
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 213M 151M 2025-03
Stryker 42M 11M 2024-09
Tandem Diabetes Care USD 1.86M 5K 2024-12
Teva Pharmaceutical Industries USD 224M 1000K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Zimmer Biomet Holdings USD 61.9M 7.6M 2024-12
Zoetis USD 51M 6M 2024-12



J&J Les Intérêts Débiteurs Sur La Dette - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.